Peter A Forsberg

9PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyRegenerative medicine (incl. stem cells)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 27, 2026
Dexamethasone prophylaxis for excessive lymphocyte expansion after cilta-cel in multiple myeloma.

Peter A Forsberg, Jacqueline A Turner, Marita Meyer

|Aug 08, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.

Beatrice M Razzo, Shonali Midha, Andrew J Portuguese

|Jul 09, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.

Beatrice M Razzo, Shonali Midha, Andrew J Portuguese

|Dec 19, 2024
Single-Cell RNA Sequencing before and after Light Chain Escape Reveals Intrapatient Multiple Myeloma Subpopulations with Divergent Osteolytic Gene Expression.

Denis Ohlstrom, Zachary J Walker, Abhishek Pandey

|May 09, 2024
MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance.

Lorraine N Davis, Zachary J Walker, Lauren T Reiman

|Feb 29, 2024
Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies.

Alana L Keller, Lauren T Reiman, Olivia Perez de Acha

Pageof 2

Frequent Collaborators

3 joint publications

Tomer M Mark

3 joint publications

Daniel W Sherbenou

2 joint publications

Andrew J Portuguese

2 joint publications

Lauren T Reiman